Financhill
Back

Intra-Cellular Therapies Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

Intra-Cellular Therapies Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 77.06 Buy
20-day SMA: 73.79 Buy
50-day SMA: 70.47 Buy
200-day SMA: 66.12 Buy
8-day EMA: 76.43 Buy
20-day EMA: 74.65 Buy
50-day EMA: 72.14 Buy
200-day EMA: 67.1 Buy

Intra-Cellular Therapies Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.89 Buy
Relative Strength Index (14 RSI): 63.64 Buy
Chaikin Money Flow: 400479 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.29 - 77.55) Buy
Bollinger Bands (100): (65.74 - 73.68) Buy

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Intra-Cellular Therapies Stock

Is Intra-Cellular Therapies Stock a Buy?

ITCI Technical Analysis vs Fundamental Analysis

Sell
47
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy or a Sell?

Intra-Cellular Therapies Stock Info

Market Cap:
8.26B
Price in USD:
78.20
Share Volume:
1.06M

Intra-Cellular Therapies 52-Week Range

52-Week High:
84.89
52-Week Low:
45.50
Sell
47
Intra-Cellular Therapies (ITCI) is a Sell

Intra-Cellular Therapies Share Price Forecast

Is Intra-Cellular Therapies Stock a Buy?

Fundamental Analysis of Intra-Cellular Therapies

Is Intra-Cellular Therapies a good investment?

  • Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.09 per share, an increase this year of $1.09 per share, and an increase next year of $1.57 per share.

Technical Analysis of Intra-Cellular Therapies

Should I short Intra-Cellular Therapies stock?

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.